...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Anti-nociceptive effect of thalidomide on zymosan-induced experimental articular incapacitation.
【24h】

Anti-nociceptive effect of thalidomide on zymosan-induced experimental articular incapacitation.

机译:沙利度胺对酵母聚糖诱导的实验性关节功能丧失的镇痛作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The anti-nociceptive effect of thalidomide on zymosan-induced articular knee joint incapacitation in rats was investigated. Thalidomide (5-45 mg/kg), given 30 min before but not 2 h after the intra-articular injection of zymosan, inhibited the nociceptive response in a dose-dependent manner. Furthermore, thalidomide pretreatment significantly reduced the concentration of tumor necrosis factor-alpha (TNF-alpha, -68.4%) in the exudate of zymosan-injected joints, but not those of interleukin-1beta, interleukin-6, CINC-1 or interleukin-10. The expression of TNF-alpha, determined by immunohistochemical staining, in synovial tissues obtained from articular joints injected with zymosan was also inhibited by thalidomide pretreatment. The anti-nociceptive effect of thalidomide was not reversed by the co-administration of an opioid receptor antagonist, naloxone, suggesting that endogenous opioids do not mediate the anti-nociceptive effect of thalidomide in this model. In conclusion, the anti-nociceptive activity of thalidomide in zymosan-induced articular incapacitation is associated with the inhibition of TNF-alpha by resident synovial cells.
机译:研究了沙利度胺对酵母聚糖诱导的大鼠膝关节功能丧失的镇痛作用。关节内注射zymosan前30分钟给予沙利度胺(5-45 mg / kg),但剂量依赖性地抑制伤害感受。此外,沙利度胺预处理可显着降低经酵母聚糖注射的关节渗出液中肿瘤坏死因子-α(TNF-alpha,-68.4%)的浓度,但不会降低白介素-1β,白介素-6,CINC-1或白介素- 10。沙利度胺预处理也可抑制由免疫组织化学染色确定的TNF-α在从注射酵母聚糖的关节关节获得的滑膜组织中的表达。联合使用阿片受体拮抗剂纳洛酮并不能逆转沙利度胺的抗伤害感受作用,表明内源性阿片样物质在该模型中不介导沙利度胺的抗伤害感受作用。总之,沙利度胺在酵母聚糖诱导的关节失能中的抗伤害感受活性与常驻滑膜细胞对TNF-α的抑制有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号